Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Starpharma Holdings Profit Margin 2011-2018 | SPHRY

Current and historical gross margin, operating margin and net profit margin for Starpharma Holdings (SPHRY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Starpharma Holdings net profit margin as of June 30, 2018 is 0%.
  
Starpharma Holdings Annual Profit Margins
Starpharma Holdings Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.295B $0.004B
Starpharma Holdings Limited is engaged in the development of dendrimer products for pharmaceutical, life science and other applications. The Company's primary product in development is VivaGel, a microbicide gel for women used for the prevention and treatment of bacterial vaginosis and a range of sexually transmitted diseases. It also develops dendrimers as specialty chemicals for industrial applications. Starpharma Holdings Limited is headquartered in Melbourne, Australia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.973B 13.44
Gilead Sciences (GILD) United States $83.801B 10.29
CSL (CSLLY) Australia $73.135B 0.00
Celgene (CELG) United States $69.882B 10.81
Vertex Pharmaceuticals (VRTX) United States $45.238B 48.89
Biogen (BIIB) United States $44.028B 7.82
Illumina (ILMN) United States $43.846B 51.51
Regeneron Pharmaceuticals (REGN) United States $31.645B 14.36
Alexion Pharmaceuticals (ALXN) United States $24.178B 12.75
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $17.012B 50.06
Exact Sciences (EXAS) United States $13.838B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.460B 0.00
Genmab (GNMSF) Denmark $12.400B 69.55
Seattle Genetics (SGEN) United States $11.636B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.952B 53.35
Alnylam Pharmaceuticals (ALNY) United States $9.766B 0.00
Galapagos (GLPG) Belgium $8.741B 0.00
QIAGEN (QGEN) Netherlands $7.697B 25.28
Bio-Techne Corp (TECH) United States $7.490B 51.75
Guardant Health (GH) United States $6.947B 0.00
BeiGene (BGNE) Cayman Islands $6.321B 0.00
Sarepta Therapeutics (SRPT) United States $6.310B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.155B 0.00
Amarin (AMRN) Ireland $6.133B 0.00
Bluebird Bio (BLUE) United States $5.898B 0.00
Exelixis (EXEL) United States $5.867B 15.25
Moderna (MRNA) United States $5.831B 0.00
Horizon Pharma Public (HZNP) Ireland $4.973B 12.64
ARGENX SE-ADR (ARGX) Netherlands $4.915B 0.00
Ascendis Pharma (ASND) Denmark $4.355B 0.00
Repligen (RGEN) United States $4.173B 80.99
China Biologic Products (CBPO) China $4.045B 25.25
Spark Therapeutics (ONCE) United States $4.018B 0.00
Blueprint Medicines (BPMC) United States $3.975B 0.00
Medicines (MDCO) United States $3.784B 0.00
MorphoSys AG (MOR) Germany $3.689B 0.00
Mirati Therapeutics (MRTX) United States $3.467B 0.00
Alkermes (ALKS) Ireland $3.367B 0.00
Immunomedics (IMMU) United States $3.348B 0.00
Emergent Biosolutions (EBS) United States $2.751B 41.33
CRISPR Therapeutics AG (CRSP) Switzerland $2.690B 0.00
Reata Pharmaceuticals (RETA) United States $2.672B 0.00
Genomic Health (GHDX) United States $2.661B 49.91
Arena Pharmaceuticals (ARNA) United States $2.588B 5.56
Ultragenyx Pharmaceutical (RARE) United States $2.551B 0.00
MyoKardia (MYOK) United States $2.508B 0.00
Amicus Therapeutics (FOLD) United States $2.493B 0.00
Halozyme Therapeutics (HALO) United States $2.416B 0.00
Acceleron Pharma (XLRN) United States $2.356B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.287B 0.00
NeoGenomics (NEO) United States $2.227B 119.11
Myriad Genetics (MYGN) United States $2.107B 22.11
Akcea Therapeutics (AKCA) United States $2.059B 0.00
Zai Lab (ZLAB) China $2.028B 0.00
Cambrex (CBM) United States $2.007B 25.37
Ligand Pharmaceuticals (LGND) United States $1.882B 23.79
UniQure (QURE) Netherlands $1.837B 0.00
Denali Therapeutics (DNLI) United States $1.822B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.724B 0.00
Insmed (INSM) United States $1.709B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.564B 0.00
REGENXBIO (RGNX) United States $1.442B 0.00
Coherus BioSciences (CHRS) United States $1.395B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.377B 0.00
Alector (ALEC) United States $1.348B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.330B 0.00
Sangamo Therapeutics (SGMO) United States $1.291B 0.00
Editas Medicine (EDIT) United States $1.276B 0.00
AnaptysBio (ANAB) United States $1.210B 0.00
RA PHARMCTL INC (RARX) United States $1.205B 0.00
Innoviva (INVA) United States $1.153B 3.33
Fate Therapeutics (FATE) United States $1.111B 0.00
Athenex (ATNX) United States $1.100B 0.00
Epizyme (EPZM) United States $1.068B 0.00
Zymeworks (ZYME) Canada $1.004B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.979B 0.00
Twist Bioscience (TWST) United States $0.977B 0.00
Cara Therapeutics (CARA) United States $0.950B 0.00
WAVE Life Sciences (WVE) Singapore $0.904B 0.00
ANI Pharmaceuticals (ANIP) United States $0.894B 14.94
BAVARIAN NORDIC (BVNRY) Denmark $0.875B 0.00
Codexis (CDXS) United States $0.852B 0.00
Arvinas (ARVN) United States $0.837B 0.00
Principia Biopharma (PRNB) United States $0.833B 434.38
Cytokineticsorporated (CYTK) United States $0.770B 0.00
Zealand Pharma (ZEAL) Denmark $0.766B 8.88
Anika Therapeutics (ANIK) United States $0.751B 26.58
ZIOPHARM Oncology Inc (ZIOP) United States $0.746B 0.00
Mesoblast (MESO) Australia $0.736B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.726B 26.21
Intellia Therapeutics (NTLA) United States $0.725B 0.00
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Vericel (VCEL) United States $0.706B 0.00
Revance Therapeutics (RVNC) United States $0.639B 0.00
MiMedx (MDXG) United States $0.586B 0.00
DBV Technologies S.A (DBVT) France $0.576B 0.00
Heska (HSKA) United States $0.546B 70.69
Achillion Pharmaceuticals (ACHN) United States $0.543B 0.00
Cellectis S.A (CLLS) France $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Retrophin (RTRX) United States $0.516B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.506B 0.00
Intra-Cellular Therapies (ITCI) United States $0.505B 0.00
Precision BioSciences (DTIL) United States $0.502B 0.00
UROGEN PHARMA (URGN) United States $0.500B 0.00
Syros Pharmaceuticals (SYRS) United States $0.486B 0.00
Stemline Therapeutics (STML) United States $0.476B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Puma Biotechnology (PBYI) United States $0.454B 0.00
Arcus Biosciences (RCUS) United States $0.439B 0.00
BioDelivery Sciences (BDSI) United States $0.423B 0.00
CytomX Therapeutics (CTMX) United States $0.421B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.419B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.417B 0.00
Agenus (AGEN) United States $0.404B 0.00
Adverum Biotechnologies (ADVM) United States $0.400B 0.00
Bellus Health (BLU) Canada $0.384B 0.00
Protagonist Therapeutics (PTGX) United States $0.383B 0.00
Merus (MRUS) Netherlands $0.383B 0.00
AC Immune SA (ACIU) Switzerland $0.361B 26.75
Gritstone Oncology (GRTS) United States $0.354B 0.00
Scholar Rock Holding (SRRK) United States $0.351B 0.00
Prothena (PRTA) Ireland $0.347B 0.00
Kadmon Holdings (KDMN) United States $0.340B 0.00
Avid Bioservices (CDMO) United States $0.328B 0.00
Theratechnologies (THERF) Canada $0.326B 0.00
Albireo Pharma (ALBO) United States $0.323B 0.00
Kindred Biosciences (KIN) United States $0.316B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.312B 0.00
Biofrontera AG (BFRA) Germany $0.312B 466.67
ADMA Biologics Inc (ADMA) United States $0.311B 0.00
Sorrento Therapeutics (SRNE) United States $0.308B 0.00
Pfenex (PFNX) United States $0.304B 0.00
Dynavax Technologies (DVAX) United States $0.304B 0.00
Cel-Sci (CVM) United States $0.300B 0.00
Clovis Oncology (CLVS) United States $0.292B 0.00
Cellular Biomedicine (CBMG) United States $0.284B 0.00
Geron (GERN) United States $0.281B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.268B 0.00
MannKind (MNKD) United States $0.262B 0.00
Senesco Technologies (ELOX) United States $0.259B 0.00
Seres Therapeutics (MCRB) United States $0.257B 0.00
PDL BioPharma (PDLI) United States $0.255B 6.56
Aeglea BioTherapeutics (AGLE) United States $0.254B 0.00
Sutro Biopharma (STRO) United States $0.252B 0.00
ChromaDex (CDXC) United States $0.250B 0.00
Inovio Pharmaceuticals (INO) United States $0.249B 0.00
Prometic Life Sciences (PFSCF) Canada $0.242B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.239B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.239B 0.00
Palatin Technologies (PTN) United States $0.232B 6.80
Athersys (ATHX) United States $0.227B 0.00
POXEL SA FRANCE (PXXLF) France $0.227B 0.00
Affimed (AFMD) Germany $0.224B 0.00
Spero Therapeutics (SPRO) United States $0.223B 0.00
Compugen (CGEN) Israel $0.222B 0.00
Cue Biopharma (CUE) United States $0.210B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.209B 0.00
Kamada (KMDA) Israel $0.208B 7.95
EXICURE INC (XCUR) United States $0.204B 0.00
Five Prime Therapeutics (FPRX) United States $0.202B 0.00
CorMedix Inc (CRMD) United States $0.200B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.195B 0.00
OSMOTICA PHARM (OSMT) United States $0.193B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.188B 0.00
XOMA (XOMA) United States $0.177B 0.00
Nicox SA (NICXF) France $0.173B 0.00
Arsanis (XFOR) United States $0.170B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.169B 0.00
Dyadic (DYAI) United States $0.165B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Acorda Therapeutics (ACOR) United States $0.163B 0.00
Novavax (NVAX) United States $0.161B 0.00
Alcobra (ARCT) United States $0.156B 0.00
Strongbridge Biopharma (SBBP) United States $0.150B 6.16
BioTime (LCTX) United States $0.150B 10.00
Paratek Pharmaceuticals (PRTK) United States $0.146B 0.00
Cerecor (CERC) United States $0.146B 0.00
Emmaus Life Sciences (EMMA) United States $0.146B 0.00
Northwest Biotherapeutics (NWBO) United States $0.145B 0.00
Abeona Therapeutics (ABEO) United States $0.144B 0.00
Adocia (ADOCY) France $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.136B 0.00
Aptinyx (APTX) United States $0.134B 0.00
NantKwest (NK) United States $0.132B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.131B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.128B 0.00
Menlo Therapeutics (MNLO) United States $0.128B 0.00
SESEN BIO, INC (SESN) United States $0.113B 0.00
Aduro Biotech (ADRO) United States $0.103B 0.00
Verastem (VSTM) United States $0.099B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Checkpoint Therapeutics (CKPT) United States $0.095B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.095B 0.00
Arbutus Biopharma (ABUS) Canada $0.094B 0.00
VTv Therapeutics (VTVT) United States $0.094B 0.00
Trevena (TRVN) United States $0.092B 0.00
OvaScience (MLND) United States $0.091B 0.00
Vaccinex (VCNX) United States $0.088B 0.00
Mersana Therapeutics (MRSN) United States $0.086B 0.00
Idera Pharmaceuticals (IDRA) United States $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.086B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.083B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Antibe Therapeutics (ATBPF) Canada $0.080B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.075B 0.00
Catalyst Biosciences (CBIO) United States $0.072B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
VBI Vaccines (VBIV) United States $0.071B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Curis (CRIS) United States $0.069B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 37.80
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
ARAVIVE, INC (ARAV) United States $0.067B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.065B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.063B 0.00
Unum Therapeutics (UMRX) United States $0.061B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.059B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
AIT Therapeutics (XAIR) United States $0.052B 0.00
VistaGen Therapeutics (VTGN) United States $0.051B 0.00
Oncobiologics (OTLK) United States $0.048B 0.00
Proteostasis Therapeutics (PTI) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
VIVUS (VVUS) United States $0.046B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.043B 0.00
BIOCARDIA INC (BCDA) United States $0.042B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Stellar Biotechnologies (EDSA) Canada $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.033B 0.00
Protalix BioTherapeutics (PLX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Apricus Biosciences (SEEL) United States $0.029B 0.00
AEterna Zentaris (AEZS) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.77
Clearside Biomedical (CLSD) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.028B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.021B 0.00
Soligenix (SNGX) United States $0.019B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
IBio (IBIO) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Benitec Biopharma (BNTC) Australia $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00